Thinking Critically: Interpreting Randomized Clinical Trials


Thinking Critically: Interpreting Randomized Clinical Trials Banner



Date & Location
Friday, September 4, 2015, 12:00 AM - Monday, January 1, 2024, 12:00 AM, Online Course

Overview

Internet Enduring Material Sponsored by the Stanford University School of Medicine. Presented by the Department of Health Research and Policy (Division of Epidemiology) at Stanford University School of Medicine

This course seeks to fulfill the clinical community’s need to improve skills in the critical evaluation of clinical research papers. Competency in critical appraisal skills can have a significant impact by improving clinical practice, quality of research projects, and peer-review of manuscripts and grants. The course will utilize efficient and engaging videos with relevant clinical examples to cover essential research methodology principles. The online format will provide opportunities for self-paced learning and practicing critical appraisal of a variety of published studies that evaluate benefit, harm, and prognosis.

Registration

  Release Date: September 4, 2015
  Latest Review Date: July 21, 2021
  Expiration Date: January 01, 2024
  Estimated Time to Complete: 2 hours
  Registration Fee: FREE

Click Begin (at the top) to learn more about how to enroll in the course.


Credits
AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours)

Objectives
At the conclusion of this activity, learners should be able to:  

  1. Analyze the concepts of randomization and blinding in reducing bias.
  2. Develop strategies to critically appraise randomized clinical trials and determine if study results are valid.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws. You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Bibliography
Guyatt GH, Rennie D. Users' guides to the medical literature. JAMA. 1993;270:2096-2097.
Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.JAMA. 1994;271:59-63.
Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1993;270:2598-2601.
Oxman AD, Sackett DL, Guyatt GH. Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA. 1993;270:2093-2095.
Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010; 152(11):726-32.

For a complete listing please see the References/Resources  section of the course.